Search research articles
Contact Us
Filters
Showing results (441-450 of 520) with videos related to
Page
of 52
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
July 1, 2026
Clinical performance of [<sup>68</sup>Ga]Ga-DOTA-FAPI-04 PET/CT in detecting recurrent disease in medullary thyroid carcinoma: a comparative analysis with [<sup>18</sup>F]F-FDG and [<sup>68</sup>Ga]Ga-DOTATATE PET/CT, alongside identification of suitable candidates for targeted radionuclide therapy
Shyam Kumar Ravada, Rahul Vithalrao Parghane, Anuja Deshmukh, et al.
Hellenic Journal of Nuclear Medicine
|
April 23, 2010
Increased 18F-FDG uptake within the reticuloendothelial system in patients with active lung cancer on PET imaging may indicate activation of the systemic immune response
Gonca G Bural, Drew A Torigian, Wengen Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 27, 2013
SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions
Thomas C Kwee, Gang Cheng, Marnix G E H Lam, et al.
Molecular Imaging and Biology
|
October 10, 2009
Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot
Asad Nawaz, Drew A Torigian, Evan S Siegelman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2011
Beta-cell imaging: opportunities and limitations
Thomas C Kwee, Sandip Basu, Babak Saboury, et al.
PET Clinics
|
May 10, 2016
Evolving Importance of Diffusion-Weighted Magnetic Resonance Imaging in Lymphoma
Thomas C Kwee, Sandip Basu, Drew A Torigian, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 5, 2014
FDG PET/CT methodology for evaluation of treatment response in lymphoma: from "graded visual analysis" and "semiquantitative SUVmax" to global disease burden assessment
Sandip Basu, Habib Zaidi, Ali Salavati, et al.
World Journal of Nuclear Medicine
|
April 14, 2021
Initial clinical evaluation of indigenous <sup>90</sup>Y-DOTATATE in sequential duo-PRRT approach (<sup>177</sup>Lu-DOTATATE and <sup>90</sup>Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability, <sup>90</sup>Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects
Rahul V Parghane, Arpit Mitra, Trupti Upadhye Bannore, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2011
A new dimension of FDG-PET interpretation: assessment of tumor biology
Thomas C Kwee, Sandip Basu, Babak Saboury, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 1, 2011
Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders
Sandip Basu, Thomas C Kwee, Robert Gatenby, et al.
Page
of 52
Search research articles
Search
Showing results (441-450 of 520) with videos related to
Sort By:
Page
of 52
European Journal of Nuclear Medicine and Molecular Imaging
|
July 1, 2026
Clinical performance of [<sup>68</sup>Ga]Ga-DOTA-FAPI-04 PET/CT in detecting recurrent disease in medullary thyroid carcinoma: a comparative analysis with [<sup>18</sup>F]F-FDG and [<sup>68</sup>Ga]Ga-DOTATATE PET/CT, alongside identification of suitable candidates for targeted radionuclide therapy
Shyam Kumar Ravada, Rahul Vithalrao Parghane, Anuja Deshmukh, et al.
Hellenic Journal of Nuclear Medicine
|
April 23, 2010
Increased 18F-FDG uptake within the reticuloendothelial system in patients with active lung cancer on PET imaging may indicate activation of the systemic immune response
Gonca G Bural, Drew A Torigian, Wengen Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 27, 2013
SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions
Thomas C Kwee, Gang Cheng, Marnix G E H Lam, et al.
Molecular Imaging and Biology
|
October 10, 2009
Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot
Asad Nawaz, Drew A Torigian, Evan S Siegelman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2011
Beta-cell imaging: opportunities and limitations
Thomas C Kwee, Sandip Basu, Babak Saboury, et al.
PET Clinics
|
May 10, 2016
Evolving Importance of Diffusion-Weighted Magnetic Resonance Imaging in Lymphoma
Thomas C Kwee, Sandip Basu, Drew A Torigian, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 5, 2014
FDG PET/CT methodology for evaluation of treatment response in lymphoma: from "graded visual analysis" and "semiquantitative SUVmax" to global disease burden assessment
Sandip Basu, Habib Zaidi, Ali Salavati, et al.
World Journal of Nuclear Medicine
|
April 14, 2021
Initial clinical evaluation of indigenous <sup>90</sup>Y-DOTATATE in sequential duo-PRRT approach (<sup>177</sup>Lu-DOTATATE and <sup>90</sup>Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability, <sup>90</sup>Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects
Rahul V Parghane, Arpit Mitra, Trupti Upadhye Bannore, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2011
A new dimension of FDG-PET interpretation: assessment of tumor biology
Thomas C Kwee, Sandip Basu, Babak Saboury, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 1, 2011
Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders
Sandip Basu, Thomas C Kwee, Robert Gatenby, et al.
Page
of 52